Extendicare Inc (EXE.TO) has shown steady performance this week, reflecting a solid position in the health care sector.
This week, Extendicare Inc's stock price has experienced a modest increase, closing at C$37.10, up 0.22% on the day and 0.27% over the week. The company has been active in expanding its operations, with recent acquisitions enhancing its service offerings in the health care sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.51B
P/E
27.2x
52W high
$37.59
52W low
$11.86
1W change
+0.27%
Beta
1.15
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 3.2% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.28
+3.2% Upside
Current Price
C$37.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
25.2%
Annualized
90-Day Vol
33.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$44.35
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$39.38 | C$36.10 โ C$42.95 |
| 60 trading days | C$41.79 | C$36.96 โ C$47.25 |
| 90 trading days | C$44.35 | C$38.16 โ C$51.55 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Extendicare's recent acquisitions and financial performance indicate a robust growth trajectory, making it a noteworthy consideration for investors focused on the health care sector.
C$37.10
Extendicare's stock has surged 76% year-to-date, reflecting strong investor confidence and market performance.
Bull case
The company's strategic acquisitions, including the recent purchase of CBI Home Health, position it well to meet the growing demand for home health care services. This move is expected to strengthen its market presence and drive future growth.
Bear case
However, despite its growth, the stock's elevated P/E ratio of 27.21 may raise concerns for value-focused investors. This suggests that the stock could be overvalued in relation to its earnings, which might make some investors hesitant.
Recent Price Action
Extendicare Inc (EXE.TO) has seen a steady increase in its stock price, closing at C$37.10, reflecting a 0.22% gain for the day and a 0.27% increase over the week. Over the past month, the stock has appreciated by 13.53%, and year-to-date, it has surged by an impressive 76%. This performance indicates strong investor confidence amidst the company's strategic growth efforts.
Company News and Developments
While there were no significant announcements this week, Extendicare's recent activities have included strategic acquisitions aimed at enhancing its home health care services. Notably, the company completed the acquisition of CBI Home Health for $570 million earlier this year, which is expected to contribute positively to revenue growth. Additionally, Extendicare has been active in financing its expansion, including a recent offering of $450 million in senior unsecured notes.
Technical Picture
From a technical perspective, Extendicare's stock is trading above its 50-day moving average of C$33.45, representing a 10.9% premium, and well above its 200-day moving average of C$25.06, indicating a robust upward trend of 48.0%. The stock has a 52-week range of C$11.86 to C$37.59, with the current price sitting at approximately 98% of this range. With a beta of 1.15, the stock exhibits slightly higher volatility compared to the overall market. However, trading volume has been relatively low, with the latest volume at 249,445 shares, which is 0.45 times the 20-day average of 554,925 shares.
Insider Activity
There are no recent insider transactions reported for Extendicare Inc that would provide additional insights into management's confidence in the company's future performance.
Advertisement
